Saab puts 9-X Biohybrid production development on hold
When Saab unveiled its 9-X BioHybrid concept at the Geneva Motor Show earlier this year it was expected be added to the Swedish brand's lineup in the next few years. In its original form, the car was built on GM's Global Compact Car (Delta) architecture which also underpins the Chevrolet Cruze and the next generation Opel Astra. In recent months Saab has decided to downsize other models, notably the 9-3 from the current mid-size Epsilon platform to the smaller Delta. That means the 9-X (likely to be called 9-1) in production will also shrink further. Saab has reportedly halted development on the 9-1 while it determines whether it wants to compact in the premium small car segment against the likes of the MINI and Fiat 500. If it does, the 9-1 will probably change its drivetrain. The concept was shown with a 200 hp flex-fuel version of GM's new 1.4L direct injected turbo 4-cylinder paired up with the company's second generation mild hybrid system. A smaller car would likely use a significantly less powerful drivetrain.
[Source: Left Lane News]
- Biggest automotive sales disappointments
- Fastest-depreciating cars in the United States
- Find and compare 2017 Models